| 000 | 01717 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513091403.0 | ||
| 264 | 0 | _c19960722 | |
| 008 | 199607s 0 0 eng d | ||
| 022 | _a0270-7306 | ||
| 024 | 7 |
_a10.1128/MCB.16.6.3179 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPomerance, M | |
| 245 | 0 | 0 |
_aThe Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation. _h[electronic resource] |
| 260 |
_bMolecular and cellular biology _cJun 1996 |
||
| 300 |
_a3179-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 |
_aCDC2 Protein Kinase _xmetabolism |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGTPase-Activating Proteins |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aGenes, mos _xdrug effects |
| 650 | 0 | 4 |
_aGenes, ras _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinase 1 |
| 650 | 0 | 4 |
_aOocytes _xmetabolism |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-mos _xbiosynthesis |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aXenopus |
| 650 | 0 | 4 | _aras GTPase-Activating Proteins |
| 650 | 0 | 4 |
_asrc Homology Domains _ximmunology |
| 700 | 1 | _aThang, M N | |
| 700 | 1 | _aTocque, B | |
| 700 | 1 | _aPierre, M | |
| 773 | 0 |
_tMolecular and cellular biology _gvol. 16 _gno. 6 _gp. 3179-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/MCB.16.6.3179 _zAvailable from publisher's website |
| 999 |
_c8648464 _d8648464 |
||